India Healthcare LLP is an authorized partner of Major Hospitals Like Apollo, Fortis, Artemis etc and is authorized to organize OPD camps in collaboration with them to create an outreach program to every corner of the world. India Healthcare LLP does not make treatment plan, all the treatment plans are drafted by Trained Medical professionals from the partners Hospitals and the treatment plan is shared on the letter head of the Hospitals for better clarity.
Doctor profile

Dr. Ankur Bahl

Consultant physician committed to accurate diagnosis and personalised treatment, working with a coordinated specialist team.

4.0 patient rating
Verified specialist
Dr. Ankur Bahl
Verified
Consultation fee
$15 / visit
Book now
Consultation
$15 / visit 4.0
Request a callback Call the clinic
At a glance
GenderMale

About Dr. Ankur Bahl

Dr. Ankur Bahl is Senior Director of Medical Oncology & Hematology-Oncology at Fortis Memorial Research Institute, Gurugram. AIIMS-educated with over 21 years of experience, he is a recognized expert in precision oncology, immunotherapy, targeted biological therapies, and modern chemotherapy protocols. He is the lead author of India's largest real-world clinical dataset on targeted Cetuximab therapy for head and neck cancers.

Full profile

Overview & Expertise

Dr. Ankur Bahl is a medical oncologist and hemato-oncology specialist practicing in North India. Serving as Senior Director of Medical Oncology at Fortis Memorial Research Institute, Gurugram, he possesses over two decades of clinical and clinical trial experience.

His core clinical focus includes administering precision immunotherapy, targeted molecular therapies, hormonal agents, and tailored chemotherapy protocols for lung cancer, head and neck malignancies, breast cancer, GI tumors, acute leukemias, and lymphomas.

Education & Academic Credentials

Dr. Bahl completed his MBBS (2003) and MD in Internal Medicine (2007) at Maulana Azad Medical College (MAMC), Delhi. He pursued his super-specialty DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi (2012).

Additionally, he completed advanced international training in drug interactions, adverse drug reactions, and pharmacovigilance at the University of Oxford, UK.

Research Leadership & Academic Forums

Dr. Bahl is celebrated for authoring India's largest real-world research dataset on Cetuximab targeted therapy in head and neck cancer patients. He previously served as Director of Medical Oncology at Max Super Speciality Hospital, Saket, and Senior Consultant at Rajiv Gandhi Cancer Institute.

He is the founder of several international oncology educational networks, including Live Oncology Tumor Boards and Evidence-Based Debates in Oncology.

Ready to consult Dr. Ankur Bahl?

Tell us about the condition and a coordinator will arrange the consultation, shortlist the right specialists, and guide the next step.

More specialists

Home Search Book Contact Call
Chat with us